Literature DB >> 23553172

Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly.

Muhammet Dural1, Giray Kabakcı, Neşe Cınar, Tomris Erbaş, Uğur Canpolat, Kadri Murat Gürses, Lale Tokgözoğlu, Ali Oto, Ergün Barış Kaya, Hikmet Yorgun, Levent Sahiner, Selçuk Dağdelen, Kudret Aytemir.   

Abstract

Cardiovascular complications are the most common causes of morbidity and mortality in acromegaly. However, there is little data regarding cardiac autonomic functions in these patients. Herein, we aimed to investigate several parameters of cardiac autonomic functions in patients with acromegaly compared to healthy subjects. We enrolled 20 newly diagnosed acromegalic patients (55% female, age:45.7 ± 12.6 years) and 32 age- and gender-matched healthy subjects. All participants underwent 24 h Holter recording. Heart rate recovery (HRR) indices were calculated by subtracting 1st, 2nd and 3rd minute heart rates from maximal heart rate. All patients underwent heart rate variability (HRV) and QT dynamicity analysis. Baseline characteristics were similar except diabetes mellitus and hypertension among groups. Mean HRR1 (29.2 ± 12.3 vs 42.6 ± 6.5, p = 0.001), HRR2 (43.5 ± 15.6 vs 61.1 ± 10.8, p = 0.001) and HRR3 (46.4 ± 16.2 vs 65.8 ± 9.8, p = 0.001) values were significantly higher in control group. HRV parameters as, SDNN [standard deviation of all NN intervals] (p = 0.001), SDANN [SD of the 5 min mean RR intervals] (p = 0.001), RMSSD [root square of successive differences in RR interval] (p = 0.001), PNN50 [proportion of differences in successive NN intervals >50 ms] (p = 0.001) and high-frequency [HF] (p = 0.001) were significantly decreased in patients with acromegaly; but low frequency [LF] (p = 0.046) and LF/HF (p = 0.001) were significantly higher in acromegaly patients. QTec (p = 0.009), QTac/RR slope (p = 0.017) and QTec/RR slope (p = 0.01) were significantly higher in patients with acromegaly. Additionally, there were significant negative correlation of disease duration with HRR2, HRR3, SDNN, PNN50, RMSSD, variability index. Our study results suggest that cardiac autonomic functions are impaired in patients with acromegaly. Further large scale studies are needed to exhibit the prognostic significance of impaired autonomic functions in patients with acromegaly.

Entities:  

Mesh:

Year:  2014        PMID: 23553172     DOI: 10.1007/s11102-013-0482-4

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  48 in total

1.  Hypertension-related factors in patients with active and inactive acromegaly.

Authors:  Daniela Fedrizzi; Ticiana Costa Rodrigues; Fabíola Costenaro; Rosana Scalco; Mauro Antônio Czepielewski
Journal:  Arq Bras Endocrinol Metabol       Date:  2011-10

Review 2.  Cardiovascular function in acromegaly.

Authors:  R N Clayton
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

3.  Peaks of QTc lengthening measured in Holter recordings as a marker of life-threatening arrhythmias in postmyocardial infarction patients.

Authors:  V Martí; J Guindo; E Homs; X Viñoles; A Bayés de Luna
Journal:  Am Heart J       Date:  1992-07       Impact factor: 4.749

4.  Arrhythmia profile in acromegaly.

Authors:  G Kahaly; K V Olshausen; S Mohr-Kahaly; R Erbel; S Boor; J Beyer; J Meyer
Journal:  Eur Heart J       Date:  1992-01       Impact factor: 29.983

5.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.

Authors:  Laurence Katznelson; John L D Atkinson; David M Cook; Shereen Z Ezzat; Amir H Hamrahian; Karen K Miller
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

6.  Occurrence of ventricular late potentials in patients with active acromegaly.

Authors:  B L Herrmann; C Bruch; B Saller; S Ferdin; N Dagres; C Ose; R Erbel; K Mann
Journal:  Clin Endocrinol (Oxf)       Date:  2001-08       Impact factor: 3.478

7.  Sympathovagal imbalance in acromegalic patients.

Authors:  Eugenia Resmini; Massimo Casu; Vittoriana Patrone; Giovanni Murialdo; Federico Bianchi; Massimo Giusti; Diego Ferone; Francesco Minuto
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

8.  Determinants of clinical outcome and survival in acromegaly.

Authors:  C Rajasoorya; I M Holdaway; P Wrightson; D J Scott; H K Ibbertson
Journal:  Clin Endocrinol (Oxf)       Date:  1994-07       Impact factor: 3.478

9.  Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure.

Authors:  K Imai; H Sato; M Hori; H Kusuoka; H Ozaki; H Yokoyama; H Takeda; M Inoue; T Kamada
Journal:  J Am Coll Cardiol       Date:  1994-11-15       Impact factor: 24.094

Review 10.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

View more
  8 in total

Review 1.  Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2017-01-02       Impact factor: 3.633

2.  Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues.

Authors:  A Comunello; F Dassie; C Martini; E De Carlo; R Mioni; M Battocchio; A Paoletta; F Fallo; R Vettor; P Maffei
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

Review 3.  Does resistance training modulate cardiac autonomic control? A systematic review and meta-analysis.

Authors:  Pooja Bhati; Jamal Ali Moiz; Geetha R Menon; M Ejaz Hussain
Journal:  Clin Auton Res       Date:  2018-08-23       Impact factor: 4.435

4.  The tendency of reduced periodontal destruction in acromegalic patients showing similar inflammatory status with periodontitis patients.

Authors:  Yesim Ozdemir; H Gencay Keceli; Nafiye Helvaci; Tomris Erbas; Rahime M Nohutcu
Journal:  Endocrine       Date:  2019-09-02       Impact factor: 3.633

Review 5.  Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?

Authors:  M Parolin; F Dassie; R Vettor; R P Steeds; P Maffei
Journal:  J Endocrinol Invest       Date:  2020-07-06       Impact factor: 4.256

6.  Assessment of fragmented QRS formation and its relationship with left ventricular hypertrophy in nonhypertensive acromegaly patients

Authors:  Muhammet Dural; Göknur Yorulmaz; Elif Sevil Alagüney; Kadir Uğur Mert; Ezgi Çamli; Ahmet Toygar Kalkan; Aysen Akalin; Nur Kebapçi; Ahmet Serdar Yilmaz; Selda Murat; Belgin Efe
Journal:  Turk J Med Sci       Date:  2021-10-21       Impact factor: 0.973

Review 7.  Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review.

Authors:  Maryam Heidarpour; Davood Shafie; Ashraf Aminorroaya; Nizal Sarrafzadegan; Ziba Farajzadegan; Rasool Nouri; Arash Najimi; Christina Dimopolou; Gunter Stalla
Journal:  J Res Med Sci       Date:  2019-04-26       Impact factor: 1.852

8.  Increased Short-Term Beat-To-Beat Variability of QT Interval in Patients with Acromegaly.

Authors:  Andrea Orosz; Éva Csajbók; Csilla Czékus; Henriette Gavallér; Sándor Magony; Zsuzsanna Valkusz; Tamás T Várkonyi; Attila Nemes; István Baczkó; Tamás Forster; Tibor Wittmann; Julius Gy Papp; András Varró; Csaba Lengyel
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.